Kaupapa Tū Wairua

  • Indigenous mushroom licence expanded + regulatory and ethics approvals secured for Phase I clinical trial

    Phase 1 of the marae-based psilocybin clinical trial protocol received full approval from the Health and Disability Ethics Committees and the Medsafe Standing Committee On Therapeutic Trials has granted full approval for the trial to proceed.

    Admin

    , ,
    Indigenous mushroom licence expanded + regulatory and ethics approvals secured for Phase I clinical trial

  • Indigenous psychedelics wānanga moves meth research closer to clinical trial 

    Over a weekend in the middle of November, a multidisciplinary team of health professionals, rongoā practitioners, artists, academics, and interested whānau and community members, met at Rangiwaho Marae in Tairāwhiti to finalise the Tū Wairua project plans for a clinical trial in 2024. Those present acknowledged recent project milestones. Project partner, Rua Bioscience recently obtained…

    Admin

    Indigenous psychedelics wānanga moves meth research closer to clinical trial 

  • How can psilocybin help with addictions?

    Some people have asked how we think psychedelics and psilocybin can help with methamphetamine dependence and other addictions. While the kaupapa we’re working on includes much more than just the mushroom and compounds it contains, here’s an extract taken from the clinical trial protocol we are working on in the section on the scientific rationale…

    Admin

    How can psilocybin help with addictions?

  • First Licence for Psilocybe Cultivation in NZ

    The granting of a licence to cultivate indigenous fungi containing psilocybin, the active compound found in psychedelic mushrooms, is the first of its kind in New Zealand and a major milestone in a Māori health science collaboration led by Rangiwaho Marae, based south of Gisborne. The licence was granted to Rua Bioscience, a biopharmaceutical business…

    Admin

    First Licence for Psilocybe Cultivation in NZ

  • Tu Wairua researchers presenting at Parliament

    Psilocybin researcher and neuroscientist Dr Mitchell Head will present at Parliament this week alongside Manu Caddie (taonga species regulatory advisor), Dr Suresh Muthukumaraswamy (Associate Professor, University of Auckland), Zach Cotogni (Blue Honey author) and Dr Jacek Kolodziej (Policy Director, NZ Drug Foundation). The session is part of the 2023 NZ Drug Foundation Parliamentary Symposium: Addressing Unmet Health Needs and Reducing Drug Harm during…

    Admin

    ,
    Tu Wairua researchers presenting at Parliament